EVRY, France--(BUSINESS WIRE)--Jan. 30, 2006--BioSystems International and Euroscreen announce that they have signed a Collaboration Agreement for a Biomarker Discovery Program in a Chronic Inflammatory Disease. BioSystems International (“BSI”) discovers, validates and qualifies biomarkers through partnerships with pharmaceutical, biotechnology and diagnostics companies and in-house research programs or academic cooperations. BSI merges pharmaceutical and diagnostics industry experience with leading scientific and technology expertise and know-how in separation science, proteomics, genomics and immunology.